Call with Dr. Priya Mehta
Kai · BioNex Therapeutics · Jun 29, 2026 • 11:16 AM
Transcript
Analysis readyKai0:00
Hi Priya, this is Kai from Freyr Solutions — I'm reaching out about Freya Fusion Platform and Agents for BioNex Therapeutics. Did I catch you at an okay moment?
Priya0:24
Sure, I've got a minute. What's this about exactly?
Kai0:49
In short, we take the routine regulatory load off your team so they can focus on strategy — former FDA and EMA reviewers, 5,000+ submissions delivered. Where does freya fusion platform and agents sit on your priority list right now?
Priya1:13
That's relevant — we're scoping this for next quarter. Can you send something over and circle back?
Kai1:38
Absolutely. I'll email a short overview of Freya Fusion Platform and Agents today and follow up next week. Who else should I include?
Priya2:02
Just me for now, thanks.
Dr. Priya Mehta
VP Regulatory Affairs
BioNex Therapeutics
Call details
What happened
Interested but timing-dependent — Priya asked Kai to send details on Freya Fusion Platform and Agents and follow up after their internal review. A callback is owed.
Call analysis
NeutralOverall sentiment
Neutral
Talk ratio
75% agent
Objections
0
Turns
6
Sentiment through the call
How the mood moved, turn by turn — higher is warmer.
Turn-by-turn heat map
Who did the talking
Share of words spoken — aim for a balanced discovery call.
Conversation participation
How often each person took a turn in the discussion.
Objections raised
What Priya pushed back on — handle these next time.
No clear objections — a smooth conversation.
Call timeline
The shape of the conversation.
Opening
0:00
Discovery
0:24
Wrap-up
2:02